Danaher Co. (NYSE:DHR) Shares Purchased by ORG Partners LLC

ORG Partners LLC raised its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 1,212.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,770 shares of the conglomerate's stock after buying an additional 2,559 shares during the period. ORG Partners LLC's holdings in Danaher were worth $636,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Teachers Insurance & Annuity Association of America bought a new position in Danaher during the 3rd quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. purchased a new stake in Danaher in the third quarter worth $40,000. FSA Wealth Management LLC purchased a new stake in Danaher in the third quarter worth $50,000. Darwin Wealth Management LLC purchased a new position in Danaher during the 3rd quarter valued at $55,000. Finally, Dunhill Financial LLC raised its holdings in Danaher by 45.1% in the 3rd quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate's stock worth $62,000 after purchasing an additional 69 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have commented on DHR. Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective for the company in a report on Friday, December 13th. StockNews.com lowered Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. UBS Group reduced their price target on Danaher from $309.00 to $305.00 and set a "buy" rating on the stock in a research note on Wednesday, October 23rd. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the company a "hold" rating in a research report on Wednesday, October 23rd. Finally, Robert W. Baird reduced their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $286.80.

Danaher Stock Down 1.3 %

NYSE DHR traded down $3.01 on Friday, reaching $235.08. 2,863,252 shares of the stock traded hands, compared to its average volume of 2,866,305. Danaher Co. has a 12 month low of $222.53 and a 12 month high of $281.70. The company has a market cap of $169.79 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 4.33 and a beta of 0.83. The company has a fifty day moving average price of $235.67 and a 200-day moving average price of $253.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the prior year, the business earned $2.02 EPS. The firm's quarterly revenue was up 3.1% on a year-over-year basis. As a group, research analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. Danaher's dividend payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.